X
X

Tom O'Brien

CEO

Prior to founding Eclipse in 1993, Tom held several leadership positions throughout his career in the medical device industry. Having mastered both disposable and capital equipment sales for companies like C.R. Bard, Tom’s track record of success quickly established Eclipse as the go-to company to launch new technology in the surgical laser industry.

Over time Tom transitioned Eclipse from a leader in the OR surgical laser market to a key player in the aesthetic laser industry. Starting in 2011 Eclipse began a new mission of increasing adoption of Platelet-rich Plasma on a national level.

His vision and leadership has helped Eclipse become one of the most successful medical device companies in its space. Tom’s new mission is to bring game-changing Eclipse technologies in Platelet-Rich Plasma, Microneedling and Shockwave Therapy to the entire globe.

X

Eclipse MicroPen® Elite Cleared by Health Canada

Regulatory clearance fuels global growth of award-winning micro-needling device

DALLAS, April 26, 2017 /PRNewswire/ — Eclipse Aesthetics®, LLC., a leading aesthetic and medical manufacturer, is pleased to announce clearance by Health Canada for the the Eclipse MicroPen® Elite, an advanced medical-grade, automated, cordless, high-speed micro-needling device.

Clinics utilize the MicroPen® Elite to aid in the improved appearance of wrinkles, stretch marks, acne scars, skin tone and texture. The device can be used on various areas including the face, neck, décolleté, arms, hands and beyond.

“We’re excited to bring the Eclipse MicroPen® Elite to the Canadian market,” said Tom O’Brien, CEO and Founder of Eclipse. “The micro-needling pen’s popularity, reliability and clinical efficacy has been highly sought after by Canadian skin-care professionals at American medical conferences. For the first time, it can now be sold though our distribution partner Salient Medical Solutions.”

“Salient’s commitment to sourcing innovative and advanced medical technology continues with its alliance with Eclipse,” says Jay Herman, President of Salient Medical Solutions. “The micro-needling pen, company’s future innovations and commitment to regulatory compliance made our decision to partner with Eclipse clear.”

The automated micro-needling pen is a safe alternative to common skin resurfacing tools, such as lasers and dermal rollers. The MicroPen® Elite, which won THE Aesthetic Industry Award for “Best Micro-Needling Device,” is affordable, portable, effective, requires minimal to no down time and provides natural-looking results.

“With the Health Canada clearance and growing global distribution of Eclipse MicroPen® Elite, we look forward to reaching a new consumer base,” said Tom Goslau, Director of International Sales. “The device will allow skin-care providers a new and more effective way to address the evolving needs of aging consumers.” [link text=’Read More’ url=’http://www.prnewswire.com/news-releases/eclipse-micropen-elite-cleared-by-health-canada-300446797.html’]

For USA & Canada visitors: EclipseMedGlobal.com is an international website that has not been evaluated by the United States Food and Drug Administration. Statements and/or claims on this site are not intended to prevent, diagnose, treat or cure any ailments or diseases. Information and product/packaging on this site is for informational purposes only and is not intended as a substitution for advice from a physician or health-care professional. Information shown on this site may describe clearances in countries other than the USA and Canada, hence it may include indications and information that are outside the scope of FDA-cleared labeling.

Do you understand and want to proceed?

 
Yes, please proceed

 

Visit the Eclipse USA Site